The Leishmania Ab Rapid Test is a lateral flow immunoassay for the qualitative detection of antibodies including IgG and IgM to the subspecies of the Leishmania donovani (L. donovani), the Visceral leishmaniasis causative protozoans, in human whole blood, serum or plasma. Recently, utilization of L. donovani specific protein in the test has improved the sensitivity and specificity dramatically.

​

Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. It is classified as a neglected tropical disease (NTD). Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of phlebotomine sand flies. There are several different forms of leishmaniasis in people. The most common forms are cutaneous leishmaniasis, which causes skin sores, and visceral leishmaniasis, which affects several internal organs (usually spleen, liver, and bone marrow). (1)

• Two band results for simple interpretation

• Detects both anti-L. donovani IgG and IgM

• Internal control included

• Reagents included

• Room temperature storage or refrigerated (2-30⁰C)

• Sensitivity: 98.4%

• Specificity: 99.6%

• Specimen: Whole Blood, Serum, Plasma

• Time to Results: 15 minutes

• Shelf Life: 24 months from the date of manufacture

Source: (1) https://www.cdc.gov/parasites/leishmaniasis/index.html